肝病患者血脂、胆碱酯酶检测的临床价值  

The clinical value of serum lipid and cholinesteruse in patients with liver diseases

作　　者：赵晶平[1] 张瑞霞[1] 杨义明[1] 

机构地区：[1]河南省新乡医学院第一附属医院,河南新乡453100

出　　处：《中国民康医学》2007年第1期3-5,共3页Medical Journal of Chinese People’s Health

摘　　要：目的:探讨肝病患者血脂、胆碱脂酶的变化及其临床意义。方法:对近两年肝病患者,血脂、胆碱脂酶、肝功结果进行回顾分析。结果:与对照组比较,急性肝炎、肝硬化、肝癌(CHOL,TG,APOB1除外)和脂肪肝,血脂下降有显著性变化(P<0.05或P<0.01);急性肝炎、肝硬化、肝癌和脂肪肝,胆碱脂酶水平变化均有显著性(P<0.05或P<0.01)。结论:血脂,胆碱脂酶水平在一定程度上能反映肝脏的功能,对于了解临床疗效、预后判断具有一定参考价值。Objective：To invest the clinical value of serum lipid and eholinesterase in patients with liver diseases. Methods： Compared to control, findings of serum lipid, eholinesterase and liver function were retrospectively analyzed for inpatients in last two years. Results： For acute hepatitis, liver cirrhosis, liver caner （ except to CHOL, TC, APOB1 ）, and lipid liver, level of serum lipid changed signitieantly （ P 〈 0.05 or P 〈 0.01 ） ; For acute hepatitis, liver cirrhosis, liver cancer and lipid liver, change of eholinesterase was significant （P 〈 0.05 or P 〈 0.01 ）. Conclusions： Level of serum lipid and eholinesterase maybe reflect function of live in some degree, and get reference valuable to verdict curative effect and prognosis.

关 键 词：肝病 血脂 胆碱酯酶 

分 类 号：R575[医药卫生—消化系统] R446.112[医药卫生—内科学]